ATP Signaling Controlling Dyskinesia Through P2X7 Receptors
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Molecular Neuroscience"
DOI: 10.3389/fnmol.2020.00111
Abstract: Dopamine replacement therapy with L-3,4-dihydroxyphenylalanine (L-DOPA) is the only temporary therapy for Parkinson’s disease (PD), but it triggers dyskinesia over time. Since dyskinesia is associated with increased neuronal firing that bolsters purinergic signaling, we now… read more here.
Keywords: controlling dyskinesia; p2x7; signaling controlling; p2x7 receptors ... See more keywords